Biotech Values

[wbart21]

ABT+FACT...TRBN








Prior to acquisition FACT entered into a partnership with TRBN for TRU-16.Nonrefundable milestone and equity investment made at the time presumably as an attempt to thwart BIIB acquisition in the teens.Deal has a $10mm 18 month termination fee if FACT or acquiree terminates w/i timeframe.ABT today included a slide reference to the trbn program at Cowen pg 9.
**tp://tinyurl.com/yfgfno5

TRBN's other significant programs were partnered with WYE at time of its acquisition by PFE.PFE has since reaffirmed/assumed those collaborative agreements.

Trbn has about $3/sh cash,manageable burn because of the foregoing and has some early validation from some solid Co's wye,fact,pfe...perhaps ABT.Anyone familiar with the promise or lack thereof of their SMIP platform from a scientific perspective?